|
Name |
Baicalin |
|
Synonyms |
Baicalein 7-O-glucuronide; 5,6-Dihydroxy-4-oxygen-2-phenyl-4H-1-benzopyran-7-beta-D-glucopyranose acid |
|
Brand |
Salus |
|
Molecular Formula |
C21H18O11 |
|
Molecular Weight |
446.36 |
|
CAS Registry Number |
21967-41-9 |
1.Baicalin be used for the treatment of paralysis after cerebrovascular disease;
2.Baicalin can remove oxygen free radicals, but also inhibit the melanin formation;
3.Baicalin will reduce cerebral vascular resistance, improve blood circulation, increase cerebral blood flow and has anti-platelet aggregation effect;
4.Baicalin has antibacterial, diuretic, anti-inflammatory, anti-metamorphosis and antispasmodic effect, and has strong anti-cancer response to physiological performance.
1) In pharmaceutical field: As pharmaceutical raw materials for clearing heat, anti- inflammation, detumescence and so on.
2) In health product industry: As products effective ingredients for improving blood circulation and soothing the nerves.
COA:
|
Items |
Standards |
Results |
|
Physical Analysis |
||
|
Description |
Brown Fine Powder | Complies |
|
Assay |
10:1 | Complies |
|
Mesh Size |
100 % pass 80 mesh | Complies |
|
Ash |
≤ 5.0% | 2.85% |
| Loss on Drying | ≤ 5.0% | 2.85% |
| Chemical Analysis | ||
| Heavy Metal | ≤ 10.0 mg/kg | Complies |
| Pb | ≤ 2.0 mg/kg | Complies |
| As | ≤ 1.0 mg/kg | Complies |
| Hg | ≤ 0.1 mg/kg | Complies |
| Microbiological Analysis | ||
| Residue of Pesticide | Negative | Negative |
| Total Plate Count | ≤ 1000cfu/g | Complies |
| Yeast&Mold | ≤ 100cfu/g | Complies |
| E.coil | Negative | Negative |
| Salmonella | Negative | Negative |
